Author

J. Gutierrez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Ecology· 1 Evolutionary Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:drug response / drug discovery· 2 Organism:zebrafish· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. Alape· 1 shared A. C. Castillo· 1 shared A. Campbell· 1 shared A. Clark· 1 shared A. Gomez· 1 shared A. Greka· 1 shared A. Hernandez· 1 shared A. Narayanan· 1 shared

Activity by Year

2020-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Alape

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Experimental effects of within-brood genetic variation on parasite resistance in a wild bird host

J. Gutierrez, C. C. Taff, C. Goncalves, S. Tupy, S. A. Knutie

This study examines how within-brood genetic variation and nestling sex affect parasite resistance in eastern bluebirds, finding that female-biased nests have lower parasite loads.

bioRxiv · May 26, 2022 · PreprintEcology

Independent duplications of the Golgi phosphoprotein 3 oncogene in birds

J. C. Opazo, M. W. Vandewege, J. Gutierrez, K. Zavala, L. Vargas-Chacoff, F. J. Morera, G. A. Mardones

The paper identifies three GOLPH3 genes in birds, finds independent duplications in non-paleognath groups, and highlights N-terminal variation and differential expression.

bioRxiv · Jan 31, 2021Evolutionary Biology

A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic

M. Malimova, E.-H. Sidhom, A. Satyam, M. Dvela-Levitt, M. Melanson, B. T. Chamberlain, S. L. Alper, J. Santos, J. Gutierrez, A. Subramanian, E. Grinkevich, E. R. Bricio, C. Kim, A. Clark, A. Watts, , A. Greka

The paper identifies Fostamatinib as a potential repurposing drug for acute lung injury by reducing MUC1 protein levels in preclinical models.

Cell Reports Medicine · Nov 1, 2020Peer-reviewedCell Biology

Development and pre-clinical characterization of two therapeutic equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19

G. Leon, M. Herrera, M. Vargas, M. Arguedas, A. Sanchez, A. Segura, A. Gomez, G. Solano, E. Corrales-Aguilar, K. Risner, A. Narayanan, C. Bailey, M. Villalta, A. Hernandez, A. Sanchez, , A. Alape

This paper develops and pre-clinically evaluates two equine-derived anti-SARS-CoV-2 polyclonal formulations for potential COVID-19 treatment, showing high neutralizing capacity against SARS-CoV-2 infection.

bioRxiv · Oct 17, 2020 · PreprintMicrobiology

Myomixer is expressed during embryonic and post-larval hyperplasia, muscle regeneration and fusion of myoblats in rainbow trout (Oncorhynchus mykiss)

M. Perello-Amoros, C. Ralliere, J. Gutierrez, J.-C. Gabillard

This study identifies and characterizes the myomixer gene in rainbow trout, showing its expression during muscle development, growth, and regeneration.

bioRxiv · Aug 28, 2020Cell Biology